Pharmacologic treatment of the adult hospitalized asthma patient

M. L. Kreutzer, Samuel Louie

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.

Original languageEnglish (US)
Pages (from-to)357-383
Number of pages27
JournalClinical Reviews in Allergy and Immunology
Volume20
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Asthma
Leukotrienes
Cholinergic Antagonists
Secondary Prevention
Magnesium
Cholinergic Agents
Adrenal Cortex Hormones
Hospitalization
Therapeutics
Education
Pharmaceutical Preparations
methylxanthine

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Pharmacologic treatment of the adult hospitalized asthma patient. / Kreutzer, M. L.; Louie, Samuel.

In: Clinical Reviews in Allergy and Immunology, Vol. 20, No. 3, 2001, p. 357-383.

Research output: Contribution to journalArticle

@article{115b411a333d4b95b5828724d354519f,
title = "Pharmacologic treatment of the adult hospitalized asthma patient",
abstract = "Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.",
author = "Kreutzer, {M. L.} and Samuel Louie",
year = "2001",
doi = "10.1385/CRIAI:20:3:357",
language = "English (US)",
volume = "20",
pages = "357--383",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Pharmacologic treatment of the adult hospitalized asthma patient

AU - Kreutzer, M. L.

AU - Louie, Samuel

PY - 2001

Y1 - 2001

N2 - Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.

AB - Acute severe asthma calls for aggressive and early therapy of a multifaceted and all-inclusive approach (Fig.2). Therapy merely begins in the ED and manifold distinct issues need to find consideration during ongoing hospital care. Currently, β-agonists, anti-cholinergic agents, and corticosteroids remain the mainstay of therapy. Methylxanthines and magnesium may find consideration in carefully selected patients. Multiple new therapeutic avenues, such as the anti-leukotriene drugs, seem promising and future studies will hopefully extend our armamentarium against life threatening complication of a common disease. Asthma education begun in the hospital may provide the platform for preventing severe acute exacerbations and hospitalization.

UR - http://www.scopus.com/inward/record.url?scp=0035019961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035019961&partnerID=8YFLogxK

U2 - 10.1385/CRIAI:20:3:357

DO - 10.1385/CRIAI:20:3:357

M3 - Article

VL - 20

SP - 357

EP - 383

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 3

ER -